The effects of ethanol on rat embryos developing in vitro

A whole-embryo culture model has been developed as a means to study ethanol embryotoxicity. Ethanol exhibited a dose-related effect on Sprague-Dawley 10-day rat embryonic development over a 2-day culture period. Growth retardation was first detected at a concentration of 390 mg/100 ml and became more marked as the ethanol concentration was increased. At a concentration of 590 mg/100 ml there were signs of abnormal development and, since the embryos still appeared viable, that concentration was taken to be teratogenic. The possible significance of the high concentrations needed to cause effects in the present study in relation to rodent models of human ethanol embryotoxicity are discussed.     

Selective inhibition of rat liver carboxylesterases by various organophosphorus diesters in vivo and in vitro

Five purified carboxylesterases/amidases of rat liver are susceptible to inhibition by various organophosphorus diesters and triesters. The inhibitory effect of these esters generally decreases in the order paraoxon>bis(4-nitrophenyl)phosphate>4-nitrophenyl-phenyl-phosphate>bis(4-cyanophenyl) phosphate>2-nitrophenyl-phenyl-phosphate. After in vivo application of radioactive bis(4-nitrophenyl) phosphate, all microsomal carboxylesterases of rat liver—including the five hydrolases investigated in vitro—are irreversibly labeled. We conclude that all carboxylic este hydrolases of rat liver that act at neutral pH can be classified as serine hydrolases. The hydrolases pI 6.2 and 6.4 that have the highest monoleylglycerol-cleaving activities are relatively insensitive to inhibition by organophosphorus diesters as compared to the hydrolases with lower pI. The very similar hydrolases pI 6.2 and 6.4 may be distinguished in vitro by the action of 0.1 mM HgCl₂, which inhibits hydrolase pI 6.4 almost completely. Among the organophosphorus diesters investigated, bis (4-cyanophenyl)phosphate is a surprisingly specific inhibitor for the acetanilide-cleaving hydrolase pI 5.6 both in vitro and in vivo. This inhibitor allows a clear discrimination between the hydrolases pI 5.2 and 5.6 that have similar substrate specificity and chemical properties. After intraperitoneal injection into mice, bis(4-cyanophenyl) phosphate exhibits extremely low toxicity.     

In vivo and in vitro effects of bromoacetylcholine on rat brain acetylcholine levels and choline acetyltransferase activity

Intraventricular injection of bromoacetylcholine to rats did not lower brain acetylcholine levels, nor did it inhibit choline acetyltransferase activity. In vitro experiments indicated that bromoacetylcholine can penetrate intact neuronal tissue and inhibit choline acetyltransferase, but that in vivo it is most likely hydrolyzed by cholinesterase before it can exert any inhibitory action. For this reason bromoacetylcholine is unsuitable for in vivo inhibition of choline acetyltransferase.     

The effect of cimetidine on in vitro and in vivo microsomal drug metabolism in the rat

The effect of cimetidine on rat liver microsomal drug metabolism in vitro and in vivo was studied. Cimetidine inhibits aminopyrine N-demethylation and benzo[a]pyrene hydroxylation in a noncompetitive manner with inhibition constants between 1 and 10 mM. Benzo[a]pyrene hydroxylation in liver microsomes from 3-methylcholanthrene-pretreated rats is not appreciably inhibited by cimetidine indicating some specificity in terms of different cytochrome P-450 forms. Cimetidine gives rise to a type II spectral change with a spectral dissociation constant of about 0.1 mM. The prolonged administration of cimetidine does not result in the induction of hepatic drug metabolism. Pretreatment of rats with cimetidine prolongs aminopyrine half-life and hexobarbital sleeping time. These results demonstrate that cimetidine is an in vitro inhibitor of microsomal drug metabolism in the rat and this inhibition leads to pharmacokinetic drug-drug interactions in vivo.     

The in vitro effects of Trolox on methylmercury-induced neurotoxicity

Methylmercury (MeHg), an environmental toxicant primarily found in fish and seafood poses a dilemma to both consumers and regulatory authorities given the nutritional benefits of fish consumption vs. possible adverse neurological damage caused by MeHg. The present study addresses whether supplementation with 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid (Trolox), alters the neuro-oxidative effects of MeHg in C6-glioma and B35-neuronal cell lines. As indicators of cytotoxicity, reduced glutathione (GSH), reactive oxygen species (ROS) and mitochondrial activity (MTT) were measured. The cellular mercury (Hg) content was measured with high resolution-inductively coupled plasma mass spectrometry (HR-ICPMS). The amount of MeHg-induced ROS was significantly reduced (p < 0.05) after treatment with 50 μM Trolox in C6 glial cell line. However, treatment with Trolox did not induce any significant increase in GSH levels or MTT activity in either of the cell lines. In addition, treatment with Trolox did not induce any significant changes in intracellular MeHg levels. The MeHg and Trolox treated C6 glial cell line differed significantly (p < 0.05) from the B35 cell line for MTT, ROS and GSH activity. These findings provide experimental evidence that preincubation with Trolox prevents MeHg-induced ROS generation in C6 glial cell line by quenching of free radicals and not by changes in intracellular GSH or MeHg content.     

Serotonin-releasing effects of substituted piperazines in vitro

The effects of various piperazine-containing compounds on the release of endogenous serotonin (5-HT) from rat hypothalamic slices were evaluated. Incubation of hypothalamic slices with m-chlorophenylpiperazine (mCPP) or m-trifluoromethylphenylpiperazine (mTFMPP) evoked a potent, dose-dependent release of endogeous 5-HT that was similar in magnitude to that seen with tryptamine, p-chloroamphetamine, or fenfluramine. In the presence of the 5-HT uptake blockers fluoxetine or chlorimipramine, this release was reduced dramatically. Furthermore, removal of calcium from the incubation medium had little effect on the drug-induced release, suggesting that the release mechanism involved displacement of 5-HT stores and not depolarization-induced exocytosis. Trazodone, MK-212, and quipazine had only small effects on release. These studies show that several piperazine-containing compounds can evoke a potent release of endogenous stores of hypothalamic 5-HT in vitro, actions which should be considered together with their direct agonist activity when interpreting the CNS effects in vivo     

Effect of anticonvulsants on in vitro prothrombin synthesis in adult and fetal rat liver

Prothrombin synthesis in a postmitochondrial supernatant fraction of rat liver from vitamin K-deficient rats was unchanged in the presence of 10^?3m concentrations of phenobarbital, phenytoin, or primidone. Warfarin (10^?5m) significantly decreased prothrombin synthesis with 4.4 X 10^?7 or 2.2 × 10^?6m vitamin K added to the incubation medium whereas phenytoin (10^?3m) had no affect. Pretreatment of vitamin K-deficient adult male rats for 2 days with phenobarbital (80 mg/kg), phenytoin (200 mg/kg), or primidone (200 mg/kg) did not alter in vitro prothrombin synthesis. Pregnant vitamin K-deficient rats were treated from the 14th to 20th day of gestation with 100 mg/kg phenytoin or 80 mg/kg phenobarbital. Although the fetuses contained significant quantities of phenytoin (95.4 ± 37.5 μg/ml serum) or phenobarbital (32.25 ± 4.51 μg/ml serum), prothrombin synthesis by fetal liver was unaffected. Feeding a diet deficient in both vitamin K and folic acid to pregnant rats treated with phenytoin (100 mg/kg) also did not alter prothrombin synthesis but appeared to increase fetal accumulation of phenytoin (289 ± 109.9 μg/ml serum).     

Potential in vitro effects of carbon nanotubes on human aortic endothelial cells

Respiratory exposure of mice to carbon nanotubes induces pulmonary toxicity and adverse cardiovascular effects associated with atherosclerosis. We hypothesize that the direct contact of carbon nanotubes with endothelial cells will result in dose-dependent effects related to altered cell function and cytotoxicity which may play a role in potential adverse pulmonary and cardiovascular outcomes. To test this hypothesis, we examined the effects of purified single- and multi-walled carbon nanotubes (SWCNT and MWCNT) on human aortic endothelial cells by evaluating actin filament integrity and VE-cadherin distribution by fluorescence microscopy, membrane permeability by measuring the lactate dehydrogenase (LDH) release, proliferation/viability by WST-1 assay, and overall functionality by tubule formation assay. Marked actin filament and VE-cadherin disruption, cytotoxicity, and reduced tubule formation occurred consistently at 24 h post-exposure to the highest concentrations [50-150 μg/10⁶ cells (1.5-4.5 μg/ml)] for both SWCNT and MWCNT tested in our studies. These effects were not observed with carbon black exposure and carbon nanotube exposure in lower concentrations [1-10 μg/10⁶ cells (0.04-0.4 μg/ml)] or in any tested concentrations at 3 h post-exposure. Overall, the results indicate that SWCNT and MWCNT exposure induce direct effects on endothelial cells in a dose-dependent manner.     

A polyacetylene from Gymnaster koraiensis exerts hepatoprotective effects in vivo and in vitro

In the present study, we isolated a polyacetylene, gymnasterkoreayne B (GKB), from Gymnaster koraiensis and investigated the effect of GKB on the protection from oxidative stress-induced cytotoxicity through induction of the expression of cellular defense enzymes. GKB induced mRNA expression and enzyme activity of NAD(P)H:quinone oxidoreductase (NQO1) in vitro and in vivo, and potently increased expression of many cellular defense genes including glutathione-S-transferases, UDP-glucuronosyltransferase, and glutathione reductase (GSR) in normal rat liver. The nuclear factor erythroid 2-related factor 2 (Nrf2) which is known to induce various antioxidant and cytoprotective genes, and the genes containing the antioxidant response element (ARE), including NQO1, hemeoxygenease-1, GSR were induced by GKB in HepG2 human hepatocarcinoma cells. Pre-treatment of the cells with GKB accelerated the production of glutathione and mitigated menadione-induced cytotoxicity in HepG2 cells. Taken together, we found that GKB was a novel inducer of phase II detoxification enzymes and cellular defense enzymes, resulting in protection of the cells from oxidative stress and hepatotoxicity through regulation of detoxifying and antioxidant systems.     

Barrier protective effects of rutin in LPS-induced inflammation in vitro and in vivo

Rutin, an active flavonoid compound, is well known to possess potent antiplatelet, antiviral and antihypertensive properties. In this study, we first investigated the possible barrier protective effects of rutin against pro-inflammatory responses in human umbilical vein endothelial cells (HUVECs) induced by lipopolysaccharide (LPS) and the associated signaling pathways. The barrier protective activities of rutin were determined by measuring permeability, monocytes adhesion and migration, and activation of pro-inflammatory proteins in LPS-activated HUVECs. We found that rutin inhibited LPS-induced barrier disruption, expression of cell adhesion molecules (CAMs) and adhesion/transendothelial migration of monocytes to human endothelial cells. Rutin also suppressed acetic acid induced-hyperpermeability and carboxymethylcellulose-induced leukocytes migration in vivo. Further studies revealed that rutin suppressed the production of tumor necrosis factor-α (TNF-α) and activation of nuclear factor-κB (NF-κB) by LPS. Collectively, these results suggest that rutin protects vascular barrier integrity by inhibiting hyperpermeability, expression of CAMs, adhesion and migration of leukocytes, thereby endorsing its usefulness as a therapy for vascular inflammatory diseases.     

Effect of vanillin and ethyl vanillin on cytochrome P450 activity in vitro and in vivo

Food safety is of extreme importance to human health. Vanillin and ethyl vanillin are the widely used food additives and spices in foods, beverages, cosmetics and drugs. The objective of the present work was to evaluate the impact of vanillin and ethyl vanillin on the activities of CYP2C9, CYP2E1, CYP3A4, CYP2B6 and CYP1A2 in human liver microsomes (HLM) in vitro, and impact on the activities of CYP1A2, CYP2C, CYP3A and CYP2E1 in rat liver microsomes (RLM) in vivo. The in vitro results demonstrated that vanillin and ethyl vanillin had no significant effect on the activity of five human CYP450 enzymes with concentration ranged from 8 to 128 μM. However, after rats were orally administered vanillin or ethyl vanillin once a day for seven consecutive days, CYP2E1 activity was increased and CYP1A2 activity was decreased in RLM. The in vivo results revealed that drug interaction between vanillin/ethyl vanillin and the CYP2E1/CYP1A2-metabolizing drugs might be possible, and also suggested that the application of the above additives in foods and drugs should not be unlimited so as to avoid the adverse interaction.     

Inhibition of the Rho/ROCK pathway prevents neuronal degeneration in vitro and in vivo following methylmercury exposure

Methylmercury (MeHg) is an environmental neurotoxicant which induces neuropathological changes in both the central nervous and peripheral sensory nervous systems. Our recent study demonstrated that down-regulation of Ras-related C3 botulinum toxin substrate 1 (Rac1), which is known to promote neuritic extension, preceded MeHg-induced damage in cultured cortical neurons, suggesting that MeHg-mediated axonal degeneration is due to the disturbance of neuritic extension. Therefore we hypothesized that MeHg-induced axonal degeneration might be caused by neuritic extension/retraction incoordination. This idea brought our attention to the Ras homolog gene (Rho)/Rho-associated coiled coil-forming protein kinase (ROCK) pathway because it has been known to be associated with the development of axon and apoptotic neuronal cell death. Here we show that inhibition of the Rho/ROCK pathway prevents MeHg-intoxication both in vitro and in vivo. A Rho inhibitor, C3 toxin, and 2 ROCK inhibitors, Fasudil and Y-27632, significantly protected against MeHg-induced axonal degeneration and apoptotic neuronal cell death in cultured cortical neuronal cells exposed to 100 nM MeHg for 3 days. Furthermore, Fasudil partially prevented the loss of large pale neurons in dorsal root ganglia, axonal degeneration in dorsal spinal root nerves, and vacuolar degeneration in the dorsal columns of the spinal cord in MeHg-intoxicated model rats (20 ppm MeHg in drinking water for 28 days). Hind limb crossing sign, a characteristic MeHg-intoxicated sign, was significantly suppressed in this model. The results suggest that inhibition of the Rho/ROCK pathway rescues MeHg-mediated neuritic extension/retraction incoordination and is effective for the prevention of MeHg-induced axonal degeneration and apoptotic neuronal cell death.     

The effect of stable strontium on the alkaline phosphatase activity of rat tissues—in vitro studies

In vitro studies on the effect of various amounts (10^?6–10^?3 M) of stable strontium (Sr²⁺) on the alkaline and acid phosphatase activities of rat tissues have shown a diverse response of the enzymes depending on the Sr²⁺ level and the tissue. Although both the enzymes manifest reduced activities at 10^?3 M Sr²⁺ in almost all the tissues studied only those of liver alkaline phosphatase and small intestine acid phosphatase were significantly affected. There was, however, no change at lower Sr²⁺ concentrations. The Sr²⁺-induced apparent inhibition of liver alkaline phosphatase, was found to be nonspecific and reversible by the concomitant addition of magnesium probably due to the manifestation of the Mg²⁺-dependent enzyme. The implications of the inhibitory action of Sr have been discussed with reference to tissue Sr content regarding the possible therapeutic use of stable Sr for minimizing the retention of Sr-90.     

Understanding the in vitro neuromuscular activity of snake venom Lys49 phospholipase A2 homologues

Phospholipases A₂ (PLA₂s) with a lysine substituting for the highly conserved aspartate 49, Lys49 PLA₂ homologues, are important myotoxic components in venoms from snakes of Viperidae family. These proteins induce conspicuous myonecrosis by a catalytically-independent mechanism. Traditionally, the Lys49 PLA₂ homologues are classified as non-neurotoxic myotoxins given their inability to cause lethality or paralytic effects when injected in vivo, even at relatively high doses. However, a series of in vitro studies has shown that several Lys49 PLA₂ homologues from Bothrops snake venoms induce neuromuscular blocking activity on nerve-muscle preparations in vitro. The interpretation of these findings has created some confusion in the literature, raising the question whether the Lys49 PLA₂ homologues present some neurotoxic activity. The present article reviews the in vitro neuromuscular effects of Lys49 PLA₂ homologues and discusses their possible mechanisms of action. It was concluded that the neuromuscular blockade induced by Lys49 PLA₂ homologues in isolated preparations is mainly a consequence of the general membrane-destabilizing effect of these toxins.     

Effects of anticonvulsants on the in vivo and in vitro release of gaba

The actions of various anticonvulsant compounds on GABA release in vivo and in vitro were studied. An in vivo, superfusion of sensorimotor cerebral cortex was employed and drugs were administered either by intraperitoneal injection, or in superfusion fluid and release of endogenous amino acids was measured. The in vitro method involved superfusion of synaptosomes, with drugs dissolved in superfusate, with monitoring of the release of pre-loaded [U¹⁴C]-GABA. Two alkyl-GABA analogues, γ-acetylenic GABA and γ-vinyl GABA caused enhanced release of GABA to superfusate both in vivo and in vitro. However, phenobarbitone, diphenyl hydantoin, sodium n-dipropyl acetate and carbamazepine were without effect on GABA release in either test system. Taurine caused no detectable GABA release in vivo, or from purified synaptosomes in vitro, but did stimulate release in vitro, from crude synaptosome preparations containing mitochondria in large quantities, though histidine and leucine were equally effective.     

Unifying the mathematical modeling of in vivo and in vitro microdialysis

A unifying approach is presented for developing mathematical models of microdialysis that are applicable to both in vitro and in vivo situations. Previous models for cylindrical probes have been limited by accommodating analyte diffusion through the surrounding medium in the radial direction only, i.e., perpendicular to the probe axis, or by incomplete incorporation of diffusion in the axial direction. Both radial and axial diffusion are included in the present work by employing two-dimensional finite element analysis. As in previous models, the nondimensional clearance modulus (Θ) represents the degree to which analyte clearance from the external medium influences diffusion through the medium for systems exhibiting analyte concentration linearity. Incorporating axial diffusion introduces a second dimensionless group, which is the length-to-radius aspect ratio of the membrane. These two parameter groups uniquely determine the external medium permeability, which is time dependent under transient conditions. At steady-state, the dependence of this permeability on the two groups can be approximated by an algebraic formula for much of the parameter ranges. Explicit steady-state expressions derived for the membrane and fluid permeabilities provide good approximations under transient conditions (quasi-steady-state assumption). The predictive ability of the unifying approach is illustrated for microdialysis of sucrose in vivo (brain) and inert media in vitro, under both well-stirred and quiescent conditions.     

Stability of nitrosoacetoxymethylmethylamine in in vitro systems and in vivo and its excretion by the rat organism

The stability of the carcinogen nitrosoacetoxymethylmethylamine (NAMM) was determined in water, serum and blood as well as in an in vivo assay. The half lifes of NAMM in the different media show that the dominant enzymatic degradation occurs within a few seconds after intravenous application. Nevertheless NAMM is stable enough for a passage through the body, which is also indicated by the determination of traces of NAMM in urine and exhalation air. This could explain the carcinogenesis of NAMM away from the application site.     

Peroxidase-mediated biodegradation of carbon nanotubes in vitro and in vivo

As a result of their unique electronic, optical, and mechanical properties, carbon nanotubes (CNTs) have been implemented in therapeutic and imaging applications. In an idealized situation, CNTs would be disposed of after they transport their theranostic payloads. Biodegradation represents an attractive pathway for the elimination of CNT carriers post-delivery and may be integral in catalyzing the release of the cargo from the delivery vehicle. Accordingly, recent research efforts have focused on peroxidase-driven biodegradation of CNTs. In this review, we not only summarize recent efforts to biodegrade CNTs in the test tube, in vitro, and in vivo, but also attempt to explore the fundamental parameters underlying degradation. Encouraged by the in vivo results obtained to date, we envision a future, where carbon-based nano-containers, which are specifically designed to target organs/cells, deliver their cargo, and biodegrade via peroxidase-driven mechanism, will represent an attractive therapeutic delivery option in nanomedicine.     

Vascular barrier protective effects of phlorotannins on HMGB1-mediated proinflammatory responses in vitro and in vivo

The phlorotannins (phloroglucinol, eckol, and dieckol) are active compounds found in Eisenia bicyclis, and have been widely investigated for their antioxidant, anti-tumor, and anti-cancer activities. In this study, we investigated the protective effects of these phlorotannins against pro-inflammatory responses in human umbilical vein endothelial cells (HUVECs) and in mice treated by high mobility group box 1 protein (HMGB1), and the signaling pathways involved. The protective activities of the phlorotannins were determined by measuring permeability, leukocyte adhesion and migration, and the activations of pro-inflammatory proteins in HMGB1-activated HUVECs. We found that the phlorotannins inhibited; lipopolysaccharide (LPS)-induced HMGB1 release, HMGB1-mediated barrier disruption, the expressions of cell adhesion molecules (CAMs), and the adhesion/transendothelial migration of leukocytes to human endothelial cells. The phlorotannins also suppressed acetic acid induced-hyperpermeability and carboxymethylcellulose-induced leukocytes migration in vivo. Further studies revealed that the hydroxyl groups on dieckol positively regulated these vascular barrier protective effects. Collectively, these results suggest that phloroglucinol, eckol, and dieckol protect vascular barrier integrity by inhibiting hyperpermeability, the expressions of CAMs, and the adhesion and migration of leukocytes, which confirms their potential usefulnesses for the treatment of vascular inflammatory diseases.